Delaware Clinical Trials Report — April 2026

For Delaware residents considering participation in clinical research, April 2026 brings a critical window of opportunity, especially for those looking to join studies before enrollment closes. Across the state, 28 clinical trials are slated to conclude within the next 90 days. This urgency is particularly relevant for healthy volunteers, as 5 of these rapidly closing studies are actively seeking participants without specific health conditions. Individuals interested in contributing to medical advancements should explore these options promptly, as their chance to participate will soon expire.

Patients managing certain health conditions also face impending deadlines to join research. Trials focused on various forms of cancer, age-related conditions, and chronic issues are among those with limited time remaining for enrollment. Conditions with trials closing soon include:

• Advanced breast cancer
• Aging
• Anatomic stage II breast cancer AJCC v8
• Anatomic stage III breast cancer AJCC v8
• Anxiety disorders and symptoms
• Arthritis
• Asthma
• Breast cancer
• Chronic granulomatous disease (CGD)
• Chronic pain

These studies represent diverse areas of medical inquiry, and their imminent closure means that interested individuals should act quickly to inquire about eligibility and enrollment.

A Glimpse at New Research: Focus on Behavioral Health

This April, Delaware saw the launch of 1 new clinical trial, a figure consistent with the single trial that opened in March 2026. This month's new opportunity focuses on behavioral health, specifically addressing developmental language disorder.

The new trial, sponsored by the University of Delaware, is a behavioral study located in Newark. It represents an important opportunity for individuals and families affected by developmental language disorder to engage with cutting-edge research aimed at improving understanding and interventions for this condition. While specific trial identifiers are not provided in this month's data, interested individuals can typically find more information through the University of Delaware's research portals or by searching for "developmental language disorder" trials in Newark, Delaware.

This single new trial contributes to the state's overall research landscape, which currently includes 294 actively recruiting clinical trials. While the number of new trials this month is modest, the ongoing research efforts continue to offer a range of options for participation.

Delaware's Research Footprint: Accessibility and Opportunities

Delaware's clinical research activities are spread across 15 cities and involve 122 research sites, indicating a broad geographic reach that enhances accessibility for residents. The new trial this month is situated in Newark, a key hub for academic research within the state, particularly given the University of Delaware's sponsorship.

While Newark is home to this month's new study, the broader distribution of research sites means that opportunities are not confined to a single metropolitan area. This statewide presence helps ensure that more Delawareans, regardless of their specific location, have the chance to participate in studies relevant to their health and interests.

Participation Insights: Healthy Volunteers and Demographics

For individuals without a specific medical condition, opportunities to contribute to medical science remain available. As noted, 5 of the trials closing soon are seeking healthy volunteers, providing a time-sensitive chance to participate. Beyond these immediate opportunities, a total of 32 clinical trials statewide are currently recruiting healthy volunteers, offering numerous avenues for those interested in supporting medical research without having a diagnosed condition.

Regarding specific demographics, the single new trial opened this month is designed to include older adults. This focus ensures that senior populations have opportunities to contribute to research, which is vital for understanding age-related health and conditions. No new trials this month were exclusively for children, females, or males, indicating a broad approach to participant eligibility for the recently launched study.

Academic institutions continue to play a vital role in Delaware's research ecosystem, with the University of Delaware sponsoring the new behavioral trial. This highlights the ongoing commitment of local universities to advancing medical knowledge and providing research opportunities within the community.

Looking Ahead: Trends in Delaware Research

The trend in new trial openings in Delaware over the past six months shows a relatively consistent, albeit low, number of new studies. Following a peak of 6 new trials in December 2025, the numbers have settled to 1 in January, 2 in February, and 1 in both March and April 2026. While this month's single new trial is modest, it underscores the continuous, albeit measured, introduction of new research opportunities in the state.

As we move through the spring, the focus for many will be on the closing window for the 28 trials nearing their enrollment deadlines. Researchers will also be preparing for future studies, continuing to address a broad spectrum of health challenges and seeking to expand the options available to Delaware residents interested in clinical trial participation.